The American KKR invests 50 million euros in Belgium with Univercells

Less than five months after receiving a 20 million euro loan from the European Investment Bank (EIB), Univercells announces a new major operation: Walloon biotech is creating a subsidiary with the American capital investment fund KKR to the industrialization of its revolutionary platform intended for the production of vaccines and products for gene and cell therapies.

Please read full article in l'Echo - February 24th 2020

  • Facebook - Gris Cercle
  • Twitter - Gris Cercle
  • LinkedIn - Gris Cercle

Inventures Investment Partners S.A. — Place Sainte-Gudule 5, 1000 Brussels, Belgium — +32 472 34 14 32 — — BE 0693.960.071

Legal Disclaimer